Human extracellular matrix-1
AssigneesUnversity of Antwerp, Human Genome Sciences, Inc.
InventorsJian Ni, Ping Feng, Patrick J. Dillon, Reiner L. Gentz, Joseph Merregaert, Patrick Smits
Life of this patent
Estimating the term…
Loading patent…
AssigneesUnversity of Antwerp, Human Genome Sciences, Inc.
InventorsJian Ni, Ping Feng, Patrick J. Dillon, Reiner L. Gentz, Joseph Merregaert, Patrick Smits
Estimating the term…
A human ECM-1 polypeptide and DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for stimulating the differentiation in growth of osteoblasts and osteoclasts, which may be used to promote the healing of bone fractures and de novo bone formation, for osteoporosis, for and to promote angiogenesis. Antagonists to the polypeptide of the present invention are also disclosed which may be utilized to treat osteodystrophy, osteohypertrophy, osteoma, osteoblastoma and cancers. Diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention.
An isolated polypeptide comprising an amino acid sequence selected from the group consisting of:
An isolated polypeptide comprising an amino acid sequence selected from the group consisting of:
An isolated first polypeptide at least 90% identical to a second polypeptide selected from the group consisting of:
An isolated first polypeptide at least 90% identical to a second polypeptide selected from the group consisting of:
An isolated polypeptide comprising an amino acid sequence selected from the group consisting of:
An isolated polypeptide consisting of at least 30 contiguous amino acid residues of SEQ ID NO:2.
An isolated polypeptide consisting of at least 30 contiguous amino acid residues encoded by the cDNA in ATCC Deposit No. 97302.
Dependencies are inferred from the claim text.